Analysis of the STEP trials showed that less than 1% of weight loss came from side effects (nausea, vomiting)
The findings suggest infant risk due to semaglutide in milk is likely negligible, and fears about a baby being exposed to semaglutide via breast milk are likely overestimated, the authors wrote
Greenwood-Van Meerveld B, Tyler K, Mohammadi E, Pietra C
Read that again, because its the missing piece almost no one explains: The molecules your $7,000-a-month biologic is designed to neutralize
and there was no difference in reported minor to moderate hypoglycemia (Table S2) between GLP-1 analogues and sitagliptin (relative risk 1.35, 95% CI 0.712.58) (Table 3)
So much of his life occurs outside the realms of what most people consider normal that it would be odd if you didnt